By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
| Currency | US Dollars |
| Share Price | $ 129.11 |
| Change Today | $ 4.97 |
| % Change | 4.00 % |
| 52 Week High | $129.39 |
| 52 Week Low | $92.92 |
| Volume | 2,257 |
| Shares Issued | 1,246.00m |
| Market Cap | $160,871m |
| RiskGrade | 120 |
| Strong Buy | 10 |
| Buy | 13 |
| Neutral | 5 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 29 |

You are here: research